Meeder Asset Management Inc Fortress Biotech, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$2.62 - $4.78 $6,636 - $12,107	-2,533 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$1.26 - $1.96 $1,115 - $1,734	885 Added 53.7%	2,533 $4,000
Q1 2019 Apr 16, 2019	SELL	$0.94 - $2.47 $25,278 - $66,423	-26,892 Reduced 94.23%	1,648 $3,000
Q4 2018 Jan 17, 2019	BUY	$0.57 - $1.53 $3,601 - $9,668	6,319 Added 28.44%	28,540 $25,000
Q3 2018 Nov 02, 2018	BUY	$1.44 - $3.13 $31,021 - $67,429	21,543 Added 3177.43%	22,221 $0
Q2 2018 Jul 24, 2018	SELL	$2.92 - $5.1 $849 - $1,484	-291 Reduced 30.03%	678 $0
Q1 2018 May 03, 2018	BUY	$3.42 - $5.35 $2,140 - $3,349	626 Added 182.51%	969 $4,000
Q3 2017 Oct 20, 2017	BUY	$3.83 - $4.89 $1,313 - $1,677	343	343 $2,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $187M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.